Literature DB >> 10449727

Studying interactions of four proteins in the yeast two-hybrid system: structural resemblance of the pVHL/elongin BC/hCUL-2 complex with the ubiquitin ligase complex SKP1/cullin/F-box protein.

A Pause1, B Peterson, G Schaffar, R Stearman, R D Klausner.   

Abstract

The yeast two-hybrid system is a powerful technique that detects interactions between two proteins and has been useful in identifying new binding partners. However, the system fails to detect protein-protein interactions that require the presence of additional components of a multisubunit complex. Here we demonstrate that the vector YIpDCE1 can be used to express elongins B and C in yeast, and that these proteins form a stable complex that interacts with the von Hippel-Lindau tumor-suppressor gene product (pVHL). Only when pVHL and elongins B and C (VBC) are present does an interaction with the cullin family member, hCUL-2, occur, forming the heterotetrameric pVHL/elongin BC/hCUL-2 complex. This system was then used to map the binding region of hCUL-2 for the VBC complex. The first amino-terminal 108 aa of hCUL-2 are necessary for interaction with the VBC complex. The elongin BC dimer acts as a bridge between pVHL and hCUL-2 because pVHL and hCUL-2 can form distinct complexes with elongins B and C. These results reveal a striking structural resemblance of pVHL/elongin BC/hCUL-2 complex with the E3-like ubiquitin ligase complex SKP1/Cullin/F-box protein with respect to protein composition and sites of interactions. Thus, it seems possible that pVHL/elongin BC/hCUL-2 complex will possess ubiquitin ligase activity targeting specific proteins for degradation by the proteasome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10449727      PMCID: PMC22243          DOI: 10.1073/pnas.96.17.9533

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  cul-1 is required for cell cycle exit in C. elegans and identifies a novel gene family.

Authors:  E T Kipreos; L E Lander; J P Wing; W W He; E M Hedgecock
Journal:  Cell       Date:  1996-06-14       Impact factor: 41.582

2.  Cdc53 targets phosphorylated G1 cyclins for degradation by the ubiquitin proteolytic pathway.

Authors:  A R Willems; S Lanker; E E Patton; K L Craig; T F Nason; N Mathias; R Kobayashi; C Wittenberg; M Tyers
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

Review 3.  Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma.

Authors:  J R Gnarra; D R Duan; Y Weng; J S Humphrey; D Y Chen; S Lee; A Pause; C F Dudley; F Latif; I Kuzmin; L Schmidt; F M Duh; T Stackhouse; F Chen; T Kishida; M H Wei; M I Lerman; B Zbar; R D Klausner; W M Linehan
Journal:  Biochim Biophys Acta       Date:  1996-03-18

4.  SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box.

Authors:  C Bai; P Sen; K Hofmann; L Ma; M Goebl; J W Harper; S J Elledge
Journal:  Cell       Date:  1996-07-26       Impact factor: 41.582

5.  Cdc34 and the F-box protein Met30 are required for degradation of the Cdk-inhibitory kinase Swe1.

Authors:  P Kaiser; R A Sia; E G Bardes; D J Lew; S I Reed
Journal:  Genes Dev       Date:  1998-08-15       Impact factor: 11.361

6.  Cellular proteins that bind the von Hippel-Lindau disease gene product: mapping of binding domains and the effect of missense mutations.

Authors:  T Kishida; T M Stackhouse; F Chen; M I Lerman; B Zbar
Journal:  Cancer Res       Date:  1995-10-15       Impact factor: 12.701

7.  Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene.

Authors:  J R Gnarra; S Zhou; M J Merrill; J R Wagner; A Krumm; E Papavassiliou; E H Oldfield; R D Klausner; W M Linehan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

8.  Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein.

Authors:  G Siemeister; K Weindel; K Mohrs; B Barleon; G Martiny-Baron; D Marmé
Journal:  Cancer Res       Date:  1996-05-15       Impact factor: 12.701

9.  Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C.

Authors:  A Kibel; O Iliopoulos; J A DeCaprio; W G Kaelin
Journal:  Science       Date:  1995-09-08       Impact factor: 47.728

10.  Inhibition of transcription elongation by the VHL tumor suppressor protein.

Authors:  D R Duan; A Pause; W H Burgess; T Aso; D Y Chen; K P Garrett; R C Conaway; J W Conaway; W M Linehan; R D Klausner
Journal:  Science       Date:  1995-09-08       Impact factor: 47.728

View more
  28 in total

1.  Loss of BRMS1 promotes a mesenchymal phenotype through NF-κB-dependent regulation of Twist1.

Authors:  Yuan Liu; Marty W Mayo; Aizhen Xiao; Emily H Hall; Elianna B Amin; Kyuichi Kadota; Prasad S Adusumilli; David R Jones
Journal:  Mol Cell Biol       Date:  2014-11-03       Impact factor: 4.272

Review 2.  HIF hydroxylation and the mammalian oxygen-sensing pathway.

Authors:  Michal Safran; William G Kaelin
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

Review 3.  Diversity in genetic in vivo methods for protein-protein interaction studies: from the yeast two-hybrid system to the mammalian split-luciferase system.

Authors:  Bram Stynen; Hélène Tournu; Jan Tavernier; Patrick Van Dijck
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

4.  The Caenorhabditis elegans cell-cycle regulator ZYG-11 defines a conserved family of CUL-2 complex components.

Authors:  Srividya Vasudevan; Natalia G Starostina; Edward T Kipreos
Journal:  EMBO Rep       Date:  2007-02-16       Impact factor: 8.807

5.  Insights into Cullin-RING E3 ubiquitin ligase recruitment: structure of the VHL-EloBC-Cul2 complex.

Authors:  Henry C Nguyen; Haitao Yang; Jennifer L Fribourgh; Leslie S Wolfe; Yong Xiong
Journal:  Structure       Date:  2015-02-05       Impact factor: 5.006

6.  An intact NEDD8 pathway is required for Cullin-dependent ubiquitylation in mammalian cells.

Authors:  Michael Ohh; William Y Kim; Javid J Moslehi; Yuzhi Chen; Vincent Chau; Margaret A Read; William G Kaelin
Journal:  EMBO Rep       Date:  2002-01-29       Impact factor: 8.807

7.  The SCF(HOS/beta-TRCP)-ROC1 E3 ubiquitin ligase utilizes two distinct domains within CUL1 for substrate targeting and ubiquitin ligation.

Authors:  K Wu; S Y Fuchs; A Chen; P Tan; C Gomez; Z Ronai; Z Q Pan
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

Review 8.  Cullin-based ubiquitin ligases: Cul3-BTB complexes join the family.

Authors:  Lionel Pintard; Andrew Willems; Matthias Peter
Journal:  EMBO J       Date:  2004-04-08       Impact factor: 11.598

9.  Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclear-cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein.

Authors:  Isabelle Groulx; Stephen Lee
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

10.  Mammalian mediator subunit mMED8 is an Elongin BC-interacting protein that can assemble with Cul2 and Rbx1 to reconstitute a ubiquitin ligase.

Authors:  Christopher S Brower; Shigeo Sato; Chieri Tomomori-Sato; Takumi Kamura; Arnim Pause; Robert Stearman; Richard D Klausner; Sohail Malik; William S Lane; Irina Sorokina; Robert G Roeder; Joan Weliky Conaway; Ronald C Conaway
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.